GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genfit SA (NAS:GNFT) » Definitions » Change In Other Working Capital

Genfit (Genfit) Change In Other Working Capital : $0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Genfit Change In Other Working Capital?

Genfit's Change In Other Working Capital for the quarter that ended in Dec. 2023 was $0.00 Mil. It means Genfit's Other Working Capital stayed the same from Sep. 2023 to Dec. 2023 .

Genfit's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was $0.00 Mil. It means Genfit's Other Working Capital increased by $0.00 Mil from Dec. 2022 to Dec. 2023 .


Genfit Change In Other Working Capital Historical Data

The historical data trend for Genfit's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genfit Change In Other Working Capital Chart

Genfit Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Genfit Quarterly Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Genfit Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genfit Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Genfit's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Genfit (Genfit) Business Description

Industry
Traded in Other Exchanges
Address
Parc Eurasante, 885, Avenue Eugene Avinee, Loos, FRA, 59120
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. The company conducts clinical trials in a variety of European and North American countries when advancing through stages of development. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Genfit (Genfit) Headlines

From GuruFocus

Genfit Hopes to Buck the Odds With NASH Drug

By Barry Cohen Barry Cohen 12-10-2019

After Drug Failure, Genfit's Cupboard Is Nearly Bare

By Barry Cohen Barry Cohen 05-14-2020